This line has been used to model SLC6A1‐related neurodevelopmental disorder, which is characterized by epilepsy, intellectual disability, autism spectrum disorders, and motor impairments (Goodspeed et al. 2020). This evidence concerns the gene SLC6A1 and epilepsy.